Оригинальные статьи 616.381-002.3-031.14-008.853.2 СВЯЗЬ АКТИВНОСТИ НАД-И НАДФ-ЗАВИСИМЫХ ДЕГИДРОГЕНАЗ ЛИМФОЦИТОВ С ИСХОДОМ РАСПРОСТРАНЕННОГО ГНОЙНОГО ПЕРИТОНИТА Савченко А.А.1,.Здзитовецкий Д.Э.2, Лузан Н.А.1 1 2 ÍÈÈ ìåäèöèíñêèõ ïðîáëåì Ñåâåðà, ã. Êðàñíîÿðñê Êðàñíîÿðñêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò èì. ïðîô. Â.Ô. Âîéíî-ßñåíåöêîãî, ã. Êðàñíîÿðñê РЕЗЮМЕ Öåëüþ èññëåäîâàíèÿ ÿâèëîñü èçó÷åíèå óðîâíåé àêòèâíîñòè ÍÀÄ(Ô)-çàâèñèìûõ äåãèäðîãåíàç ëèìôîöèòîâ ïðè ðàçëè÷íûõ èñõîäàõ ðàñïðîñòðàíåííîãî ãíîéíîãî ïåðèòîíèòà (ÐÃÏ). Àêòèâíîñòü ôåðìåíòîâ â ëèìôîöèòàõ êðîâè îïðåäåëÿëàñü áèîëþìèíåñöåíòíûì ìåòîäîì. Óñòàíîâëåíî, ÷òî ó áîëüíûõ ñ íåáëàãîïðèÿòíûì èñõîäîì ÐÃÏ â ëèìôîöèòàõ êðîâè áîëåå âûðàæåííî îñóùåñòâëÿþòñÿ ðåàêöèè ëèïèäíîãî àíàáîëèçìà è êàòàáîëèçìà êñåíîáèîòèêîâ. Íåçàâèñèìî îò èñõîäà çàáîëåâàíèÿ â ëèìôîöèòàõ êðîâè áîëüíûõ ÐÃÏ ñíèæåíû óðîâíè àêòèâíîñòè ôåðìåíòîâ, îïðåäåëÿþùèõ èíòåíñèâíîñòü àíàýðîáíîãî è àýðîáíîãî äûõàíèÿ, à òàêæå óðîâåíü ïëàñòè÷åñêèõ ïðîöåññîâ ïðè àêòèâàöèè ðåàêöèé ëèïèäíîãî êàòàáîëèçìà è ïåðåíîñà ïðîäóêòîâ ÷åðåç ãëèöåðîë-3-ôîñôàòäåãèäðîãåíàçó íà îêèñëèòåëüíîâîññòàíîâèòåëüíûå ðåàêöèè ãëèêîëèçà. Èñõîäÿ èç èíôîðìàòèâíîñòè óðîâíåé àêòèâíîñòè ÍÀÄ(Ô)çàâèñèìûõ äåãèäðîãåíàç â íåéðîñåòåâîé ìîäåëè ïðè êëàññèôèêàöèè ïî èñõîäó çàáîëåâàíèÿ, ïðåäëàãàåòñÿ ìåòàáîëè÷åñêèé êîýôôèöèåíò, îáëàäàþùèé ïðîãíîñòè÷åñêîé çíà÷èìîñòüþ. КЛЮЧЕВЫЕ СЛОВА: ðàñïðîñòðàíåííûé ãíîéíûé ïåðèòîíèò, èñõîä çàáîëåâàíèÿ, ÍÀÄ-çàâèñèìûå äåãèäðîãåíàçû, ÍÀÄÔ-çàâèñèìûå äåãèäðîãåíàçû, ëèìôîöèòû, ìåòàáîëèçì. Введение Íåñìîòðÿ íà äîñòèæåíèÿ â ìåäèöèíå, ëåòàëüíîñòü ïðè ðàñïðîñòðàíåííîì ãíîéíîì ïåðèòîíèòå (ÐÃÏ), ÿâëÿþùàÿñÿ ãëàâíûì êðèòåðèåì îöåíêè ýôôåêòèâíîñòè ïðèìåíÿåìûõ ñïîñîáîâ ëå÷åíèÿ, óäåðæèâàåòñÿ íà óðîâíå 20–30%, äîñòèãàÿ íàèáîëåå âûñîêèõ öèôð (50% è áîëåå) ïðè òðåòè÷íîì ïåðèòîíèòå è ïåðèòîíèòå, ñîïðîâîæäàþùåìñÿ ðàçâèòèåì ïîëèîðãàííîé íåäîñòàòî÷íîñòè è ñåïòè÷åñêîãî øîêà [1, 2].  ñâÿçè ñ ýòèì ïîÿâëÿåòñÿ íåîáõîäèìîñòü ïîäðîáíîãî èññëåäîâàíèÿ ìîëåêóëÿðíî-êëåòî÷íûõ ìåõàíèçìîâ âîñïàëèòåëüíîé ðåàêöèè ïðè ïåðèòîíèòå. Îäíèì èç ïåðñïåêòèâíûõ íàïðàâëåíèé, ïîçâîëÿþùèõ îõàðàêòåðèçîâàòü ïàòîãåíåç íàðóøåíèÿ ðåàêòèâíîñòè èììóííîé ñèñòåìû ïðè èíôåêöèîííî-âîñïàëèòåëüíûõ ïðîöåññàõ, ÿâëÿåòñÿ èçó÷åíèå ìåòàáîëèçìà êëåòîê èììóííîé ñèñòåìû. Íà ñåãîäíÿøíèé äåíü óñòàíîâëåíî, ÷òî ôóíêöèîíàëüíûå ïðîÿâëåíèÿ ëèìôîöèòîâ, íàïðèìåð, òàêèå êàê äèôôåðåíöèðîâêà, ïðîëèôåðàöèÿ, ñèíòåç ðåöåïòîðîâ è öèòîêèíîâ, îñóùåñòâëÿþòñÿ òîëüêî ïðè ñîîòâåòñòâóþùåì èçìåíåíèè èõ Ñàâ÷åíêî Àíäðåé Àíàòîëüåâè÷, òåë.: +7-9059713715; e-mail: [email protected] ìåòàáîëèçìà [3–5].  ñâÿçè ñ òåì ÷òî ôóíêöèîíàëüíàÿ àêòèâíîñòü ëèìôîöèòîâ âî ìíîãîì îïðåäåëÿåò òå÷åíèå è èñõîä èíôåêöèîííî-âîñïàëèòåëüíûõ çàáîëåâàíèé [6, 7], íåîáõîäèìî îöåíèòü ñòåïåíü íàðóøåíèÿ âíóòðèêëåòî÷íûõ ìåòàáîëè÷åñêèõ ïðîöåññîâ ïðè ïåðèòîíèòå. Öåëü èññëåäîâàíèÿ – èçó÷èòü óðîâíè àêòèâíîñòè ÍÀÄ(Ô)-çàâèñèìûõ äåãèäðîãåíàç ëèìôîöèòîâ êðîâè ó áîëüíûõ ðàñïðîñòðàíåííûì ãíîéíûì ïåðèòîíèòîì ïðè áëàãîïðèÿòíîì è íåáëàãîïðèÿòíîì èñõîäàõ çàáîëåâàíèÿ.  êà÷åñòâå ïîêàçàòåëåé âíóòðèêëåòî÷íîãî ìåòàáîëèçìà âûáðàíû ÍÀÄ(Ô)-çàâèñèìûå äåãèäðîãåíàçû, òàê êàê, âî-ïåðâûõ, îñíîâíûìè ïåðåíîñ÷èêàìè ýëåêòðîíîâ â êëåòêàõ ÿâëÿþòñÿ ïèðèäèíîâûå íóêëåîòèäû, à îòñþäà – àêòèâíîå ó÷àñòèå îêñèäîðåäóêòàç â áèîýíåðãåòè÷åñêèõ ïðîöåññàõ; âî-âòîðûõ, ÍÀÄ(Ô)-çàâèñèìûå äåãèäðîãåíàçû, ó÷àñòâóÿ â íàïðàâëåííîé êîîðäèíàöèè ñîïðÿæåííûõ ìåòàáîëè÷åñêèõ ïîòîêîâ, â çíà÷èòåëüíîé ñòåïåíè îáóñëàâëèâàþò àäàïòèâíûå èçìåíåíèÿ êëåòî÷íîãî îáìåíà âåùåñòâ [8–10]. Материал и методы Ïîä íàøèì íàáëþäåíèåì íàõîäèëñÿ 51 áîëüíîé ñ ÐÃÏ (23 ìóæ÷èí è 28 æåíùèí) âíåáîëüíè÷íîãî è ãîñïèòàëüíîãî ïðîèñõîæäåíèÿ, ïðîõîäèâøèé ëå÷åíèå â Бюллетень сибирской медицины, 2014, том 13, № 5, с. 79–86 79 Савченко А.А.,.Здзитовецкий Д.Э., Лузан Н.А. Связь активности НАД-и НАДФ-зависимых дегидрогеназ лимфоцитов с исходом РГП îòäåëåíèè ãíîéíîé õèðóðãèè è îòäåëåíèè ðåàíèìàöèè è èíòåíñèâíîé òåðàïèè ÌÓÇ «ÃÁÑÌÏ èì. Í.Ñ. Êàðïîâè÷à» ã. Êðàñíîÿðñêà. Ñðåäíèé âîçðàñò ïàöèåíòîâ ñîñòàâèë (54,2 ± 19,2) ãîäà. Èç èññëåäîâàíèÿ áûëè èñêëþ÷åíû áîëüíûå, ó êîòîðûõ ïåðèòîíèò áûë îñëîæíåíèåì ïàíêðåîíåêðîçà, íåîïåðàáåëüíûõ îíêîëîãè÷åñêèõ çàáîëåâàíèé îðãàíîâ áðþøíîé îáëàñòè è íåîïåðàáåëüíîãî íàðóøåíèÿ ìåçåíòåðèàëüíîãî êðîâîîáðàùåíèÿ. Èñõîäíóþ ñòåïåíü òÿæåñòè áîëüíûõ îïðåäåëÿëè ïî øêàëå SAPSII [11], òÿæåñòü ÐÃÏ èñõîäíî – ïî Ìàíãåéìñêîìó èíäåêñó ïåðèòîíèòà è èíäåêñó áðþøíîé ïîëîñòè [12, 13]. Íàëè÷èå è ñòåïåíü âûðàæåííîñòè ïîëèîðãàííîé íåäîñòàòî÷íîñòè èñõîäíî è â äèíàìèêå îïðåäåëÿëè ïî øêàëå SOFA [14]. Ïðè îöåíêå òÿæåñòè ñèíäðîìà ñèñòåìíîé âîñïàëèòåëüíîé ðåàêöèè ïðèäåðæèâàëèñü êðèòåðèåâ ACCP/SCCM [15].  êà÷åñòâå êîíòðîëÿ îáñëåäîâàíî 75 çäîðîâûõ ëþäåé àíàëîãè÷íîãî âîçðàñòíîãî äèàïàçîíà. Âûäåëåíèå îáùåé ôðàêöèè ëèìôîöèòîâ îñóùåñòâëÿëè ïî îáùåïðèíÿòîìó ìåòîäó â ãðàäèåíòå ïëîòíîñòè ôèêîëë-óðîãðàôèíà ñ ïîñëåäóþùåé î÷èñòêîé îò ïðèëèïàþùèõ êëåòîê. Èññëåäîâàíèå àêòèâíîñòè ÍÀÄ(Ô)çàâèñèìûõ äåãèäðîãåíàç â ëèìôîöèòàõ êðîâè ïðîâåäåíî ñ ïîìîùüþ áèîëþìèíåñöåíòíûõ ìåòîäîâ [16]. Ìåòàáîëèçì ëèìôîöèòîâ îöåíèâàëè ïî àêòèâíîñòè ñëåäóþùèõ ôåðìåíòîâ:ãëþêîçî-6-ôîñôàòäåãèäðîãåíàçû (Ã6ÔÄÃ), ãëèöåðîë-3-ôîñôàòäåãèäðîãåíàçû (Ã3ÔÄÃ), ìàëèê-ôåðìåíòà (ÍÀÄÔÌÄÃ), ÍÀÄ- è ÍÀÄÍ-çàâèñèìîé ðåàêöèè ëàêòàòäåãèäðîãåíàçû (ËÄà è ÍÀÄÍ-ËÄÃ), ÍÀÄ- è ÍÀÄÍ-çàâèñèìîé ðåàêöèè ìàëàòäåãèäðîãåíàçû (ÌÄà è ÍÀÄÍ-ÌÄÃ), ÍÀÄÔ- è ÍÀÄÔÍ-çàâèñèìîé ãëóòàìàòäåãèäðîãåíàçû (ÍÀÄÔÃÄà è ÍÀÄÔÍ-ÃÄÃ), ÍÀÄè ÍÀÄÍ-çàâèñèìîé ãëóòàìàòäåãèäðîãåíàçû (ÍÀÄÃÄà è ÍÀÄÍ-ÃÄÃ), ÍÀÄ- è ÍÀÄÔ-çàâèñèìûõ èçîöèòðàòäåãèäðîãåíàç (ÍÀÄÈÖÄà è ÍÀÄÔÈÖÄÃ) è ãëóòàòèîíðåäóêòàçû (ÃÐ). Àêòèâíîñòü ÍÀÄ(Ô)-çàâèñèìûõ äåãèäðîãåíàç âûðàæàëè â ôåðìåíòàòèâíûõ åäèíèöàõ íà 104 êëåòîê, ãäå 1 Å = 1 ìêìîëü/ìèí [8]. Èññëåäîâàíèå ïðîâîäèëè íà ôåðìåíòàòèâíîì ïðåïàðàòå NÀD(Ð): FMN-îêñèäîðåäóêòàçà-ëþöèôåðàçà èç Photobacterium leiognathi (ïîëó÷åí â Èíñòèòóòå áèîôèçèêè ÑÎ ÐÀÍ, Êðàñíîÿðñê). Âñå èññëåäîâàíèÿ âûïîëíåíû ñ èíôîðìèðîâàííîãî ñîãëàñèÿ èñïûòóåìûõ è â ñîîòâåòñòâèèñ Õåëüñèíêñêîé äåêëàðàöèåé Âñåìèðíîé ìåäèöèíñêîé àññîöèàöèè «Ýòè÷åñêèå ïðèíöèïû ïðîâåäåíèÿ íàó÷íûõ ìåäèöèíñêèõ èññëåäîâàíèé ñ ó÷àñòèåì ÷åëîâåêà» ñ ïîïðàâêàìè 2000 ã. è «Ïðàâèëàìè êëèíè÷åñêîé ïðàêòèêè â Ðîññèéñêîé Ôåäåðàöèè», óòâåðæäåííûìè Ïðèêàçîì Ìèíçäðàâà ÐÔ îò 19.06.2003 ã. ¹ 266. Ñòàòèñòè÷åñêèé àíàëèç îñóùåñòâëÿëè â ïàêåòå ïðèêëàäíûõ ïðîãðàìì Statistica 8.0 for Windows 80 (StatSoft Inc., 2007).Îïèñàíèå âûáîðêè ïðîèçâîäèëè ñ ïîìîùüþ ïîäñ÷åòà ìåäèàíû Ìå è èíòåðêâàðòèëüíîãî ðàçìàõà â âèäå 25-ãî è 75-ãî ïðîöåíòèëåé (LQ–UQ). Äîñòîâåðíîñòü ðàçëè÷èé ìåæäó ïîêàçàòåëÿìè íåçàâèñèìûõ âûáîðîê îöåíèâàëè ïî íåïàðàìåòðè÷åñêîìó êðèòåðèþ Ìàííà–Óèòíè. Äëÿ ðåøåíèÿ çàäà÷ ïîääåðæêè ïðèíÿòèÿ ðåøåíèé èñïîëüçîâàëè ìåòîä íåéðîííûõ ñåòåé. Íåéðîñåòåâîé êëàññèôèêàòîð ïðåäñòàâëÿåò ñîáîé àëãîðèòì, ñïîñîáíûé ê îáó÷åíèþ è ïðèíÿòèþ ðåøåíèé, íà îñíîâå ðàññ÷èòàííûõ âåñîâûõ êîýôôèöèåíòîâ. Íåéðîñåòü âêëþ÷àåò íàáîð âõîäíûõ íåéðîíîâ (14 ïîêàçàòåëåé àêòèâíîñòè ôåðìåíòîâ + 2) è ìàòðèöó ñèíàïñîâ (ñâÿçè ìåæäó íåéðîíàìè). Êëàññèôèêàöèÿ(ïðèíÿòèå ðåøåíèÿ) ïðîèñõîäèò â çàâèñèìîñòè îò çíà÷åíèé, ðåãèñòðèðóåìûõ íà âûõîäíûõ íåéðîíàõ. Îáó÷åíèå íåéðîííîé ñåòè ïðîâîäèëîñü ìåòîäîì îáðàòíîãî ðàñïðîñòðàíåíèÿ îøèáêè. Äëÿ ðàñ÷åòà ïàðàìåòðîâ ìîäåëè ïðèíÿòèÿ ðåøåíèé èñïîëüçîâàëàñü îáó÷àþùàÿ âûáîðêà, ñîñòîÿùàÿ èç îáúåêòîâ, êàæäûé èç êîòîðûõ õàðàêòåðèçóåòñÿ îïðåäåëåííûì íàáîðîì ïîêàçàòåëåé àêòèâíîñòè ôåðìåíòîâ â ëèìôîöèòàõ îäíîãî ÷åëîâåêà. Âñå îáúåêòû îáó÷àþùåé âûáîðêè íåéðîñåòåâîãî êëàññèôèêàòîðà ðàçáèòû íà êëàññû (áîëüíûå ñ áëàãîïðèÿòíûì è íåáëàãîïðèÿòíûì èñõîäàìè çàáîëåâàíèÿ), â îòíîøåíèè êîòîðûõ è ðåøàåòñÿ çàäà÷à êëàññèôèêàöèè. Ïî îêîí÷àíèþ êëàññèôèêàöèè ïîäñ÷èòûâàåòñÿ èíôîðìàòèâíîñòü ââîäèìûõ ïîêàçàòåëåé [17]. Результаты и обсуждение Êëèíè÷åñêèå ïðîÿâëåíèÿ ñèíäðîìà ñèñòåìíîé âîñïàëèòåëüíîé ðåàêöèè ïåðåä ïåðâè÷íîé îïåðàöèåé ïî ïîâîäó ïåðèòîíèòà îòìå÷àëèñü ó 47 áîëüíûõ ((94,0 ± 3,4)%). Ïðåîáëàäàëè áîëüíûå ñ òÿæåëûìè ïðîÿâëåíèÿìè ñèíäðîìà ñèñòåìíîé âîñïàëèòåëüíîé ðåàêöèè (òÿæåëûé ñåïñèñ è ñåïòè÷åñêèé øîê) – 34 ((68,0 ± 6,6)%). Òÿæåñòü ñîñòîÿíèÿ ïî øêàëå SAPS II ñîñòàâèëà 29 (16–37) áàëëà. Âûðàæåííîñòü ïîëèîðãàííîé íåäîñòàòî÷íîñòè ïî øêàëå SOFA – 2 (1–4) áàëëà. Èíòðàîïåðàöèîííàÿ îöåíêà òÿæåñòè ïåðèòîíèòà äàëà ñëåäóþùèå ðåçóëüòàòû: Ìàíãåéìñêèé èíäåêñ ïåðèòîíèòà â ñðåäíåì ñîñòàâèë 28 (25–33), èíäåêñ áðþøíîé ïîëîñòè – â ñðåäíåì 14 (13–14). Ïðè èññëåäîâàíèè óðîâíåé àêòèâíîñòè ÍÀÄÔçàâèñèìûõ äåãèäðîãåíàç ëèìôîöèòîâ êðîâè ó áîëüíûõ ïåðèòîíèòîì â çàâèñèìîñòè îò èñõîäà çàáîëåâàíèÿ îáíàðóæåíî, ÷òî àêòèâíîñòü ÍÀÄÔÌÄà â ëèìôîöèòàõ êðîâè áîëüíûõ ïåðèòîíèòîì ñíèæåíà îòíîñèòåëüíî êîíòðîëüíûõ çíà÷åíèé êàê ïðè áëàãîïðèÿòíîì, òàê è ïðè íåáëàãîïðèÿòíîì èñõîäå (ðèñ. 1, à). Îäíàêî ó áîëüíûõ ñ íåáëàãîïðèÿòíûì èñõîäîì ïîíèæåíèå óðîâíÿ àêòèâíîñòè áîëåå âûðàæåíî, ÷åì ïðè áëàãîïðèÿòíîì èñõîäå. Бюллетень сибирской медицины, 2014, том 13, № 5, с. 79–86 Оригинальные статьи Ðèñ. 1. Àêòèâíîñòü ÍÀÄÔ-çàâèñèìûõ äåãèäðîãåíàç â ëèìôîöèòàõ êðîâè ó áîëüíûõ ÐÃÏ â çàâèñèìîñòè îò èñõîäà çàáîëåâàíèÿ. Çäåñü è íà ðèñ. 2 è 3: ð1 – ñòàòèñòè÷åñêè äîñòîâåðíûå ðàçëè÷èÿ ñ àêòèâíîñòüþ ôåðìåíòîâ êîíòðîëüíîé ãðóïïû; ð2 – ñòàòèñòè÷åñêè äîñòîâåðíûå ðàçëè÷èÿ ñ àêòèâíîñòüþ ôåðìåíòîâ áîëüíûõ ñ áëàãîïðèÿòíûì èñõîäîì ÐÃÏ Óðîâíè àêòèâíîñòè Ã6ÔÄÃ, ÍÀÄÔÃÄÃ, ÍÀÄÔÈÖÄÃ, ÃÐ è ÍÀÄÔÍ-ÃÄà â ëèìôîöèòàõ ó áîëüíûõ ïåðèòîíèòîì ñíèæåíû îòíîñèòåëüíî êîíòðîëüíûõ çíà÷åíèé íåçàâèñèìî îò èñõîäà çàáîëåâàíèÿ (ðèñ. 1, á–å). Ïðè èññëåäîâàíèè óðîâíåé àêòèâíîñòè ÍÀÄçàâèñèìûõ äåãèäðîãåíàç ëèìôîöèòîâ êðîâè ó áîëüíûõ ïåðèòîíèòîì îáíàðóæåíî, ÷òî àêòèâíîñòü Ã3ÔÄà ïîâûøåíà, òîãäà êàê àêòèâíîñòü ËÄÃ, ÌÄà è ÍÀÄÃÄà ñíèæåíà îòíîñèòåëüíî êîíòðîëüíûõ óðîâíåé íåçàâèñèìî îò èñõîäà çàáîëåâàíèÿ (ðèñ. 2, à–ã). Àíàëîãè÷íûì îáðàçîì èçìåíÿåòñÿ àêòèâíîñòü ÍÀÄÍ- çàâèñèìûõ ðåàêöèé äåãèäðîãåíàç â ëèìôîöèòàõ êðîâè áîëüíûõ ïåðèòîíèòîì: ñíèæåíà îòíîñèòåëüíî êîíòðîëüíûõ óðîâíåé íåçàâèñèìî îò èñõîäà çàáîëåâàíèÿ (ðèñ. 3, à–â). Âàðèàáåëüíîñòü èçìåíåíèé óðîâíåé àêòèâíîñòè ÍÀÄ(Ô)-çàâèñèìûõ äåãèäðîãåíàç â ëèìôîöèòàõ ó áîëüíûõ ïåðèòîíèòîì â çàâèñèìîñòè îò èñõîäà çàáîëåâàíèÿ îêàçàëàñü èíôîðìàòèâíà â ìîäåëè íåéðîñåòåâîãî àíàëèçà (ðèñ. 4). Îáíàðóæåíî, ÷òî íàèáîëåå èíôîðìàòèâíûìè ïîêàçàòåëÿìè ìîäåëè ÿâëÿþòñÿ óðîâíè àêòèâíîñòè ËÄÃ, ÌÄÃ, ÃÐ, ÍÀÄÔÍ-ÃÄà è ÍÀÄÔÌÄÃ. Бюллетень сибирской медицины, 2014, том 13, № 5, с. 79–86 81 Савченко А.А.,.Здзитовецкий Д.Э., Лузан Н.А. Связь активности НАД-и НАДФ-зависимых дегидрогеназ лимфоцитов с исходом РГП Ðèñ. 2. Àêòèâíîñòü ÍÀÄ-çàâèñèìûõ äåãèäðîãåíàç â ëèìôîöèòàõ êðîâè ó áîëüíûõ ÐÃÏ â çàâèñèìîñòè îò èñõîäà çàáîëåâàíèÿ Ðèñ. 3. Àêòèâíîñòü ÍÀÄÍ-çàâèñèìûõ äåãèäðîãåíàç â ëèìôîöèòàõ êðîâè ó áîëüíûõ ÐÃÏ â çàâèñèìîñòè îò èñõîäà çàáîëåâàíèÿ 82 Бюллетень сибирской медицины, 2014, том 13, № 5, с. 79–86 Оригинальные статьи Ðèñ. 4. Èíôîðìàòèâíîñòü ÍÀÄ- è ÍÀÄÔ-çàâèñèìûõ äåãèäðîãåíàç ëèìôîöèòîâ ó áîëüíûõ â çàâèñèìîñòè îò èñõîäà ÐÃÏ â ìîäåëè íåéðîñåòåâîãî êëàññèôèêàòîðà Èññëåäóåìûå ôåðìåíòû çàíèìàþò êëþ÷åâûå ïîçèöèè íà ðàçíûõ ìåòàáîëè÷åñêèõ ïóòÿõ êëåòêè, õàðàêòåðèçóÿ îñíîâíûå îáìåííûå ïðîöåññû è òåì ñàìûì îïðåäåëÿÿ ôóíêöèîíàëüíûå âîçìîæíîñòè ëèìôîöèòîâ.  öåëîì ìåòàáîëèçì ëèìôîöèòîâ ó áîëüíûõ ïåðèòîíèòîì õàðàêòåðèçóåòñÿ íèçêîé àêòèâíîñòüþ áîëüøèíñòâà èññëåäóåìûõ ÍÀÄÔ- è ÍÀÄÔÍ-çàâèñèìûõ äåãèäðîãåíàç (ÍÀÄÔÌÄÃ, Ã6ÔÄÃ, ÍÀÄÔÃÄÃ, ÍÀÄÔÈÖÄÃ, ÃÐ è ÍÀÄÔÍ-ÃÄÃ) è íåêîòîðûõ ÍÀÄ- è ÍÀÄÍ-çàâèñèìûõ ôåðìåíòîâ (Ã3ÔÄÃ, ËÄÃ, ÌÄÃ, ÍÀÄÃÄÃ, ÍÀÄÍ-ËÄÃ, ÍÀÄÍ-ÌÄà è ÍÀÄÍ-ÃÄÃ). Ïðè ýòîì àêòèâíîñòü òîëüêî ÍÀÄÔÌÄà ðàçëè÷àåòñÿ â çàâèñèìîñòè îò èñõîäà çàáîëåâàíèÿ. ÍÀÄÔÌÄà – ôåðìåíò, ïðèíèìàþùèé àêòèâíîå ó÷àñòèå â ñèñòåìå ëèïèäíîãî àíàáîëèçìà è êàòàáîëèçìà êñåíîáèîòèêîâ [3, 9]. Ñíèæåíèå åãî àêòèâíîñòè â ëèìôîöèòàõ êðîâè áîëüíûõ ïåðèòîíèòîì îïðåäåëÿåò ïîíèæåííóþ èíòåíñèâíîñòü àíàáîëèçìà ëèïèäîâ. Ïðè÷åì ó áîëüíûõ ñ íåáëàãîïðèÿòíûì èñõîäîì çàáîëåâàíèÿ àêòèâíîñòü ôåðìåíòà çíà÷èòåëüíî ñíèæåíà, â òîì ÷èñëå è îòíîñèòåëüíî âûÿâëåííîé ó ïàöèåíòîâ ñ áëàãîïðèÿòíûì èñõîäîì çàáîëåâàíèÿ. Ã3ÔÄà – ôåðìåíò, ïðèíèìàþùèé ó÷àñòèå â ïðîöåññàõ ëèïèäíîãî êàòàáîëèçìà è ãëèöåðîëôîñôàòíîì ÷åëíî÷íîì ìåõàíèçìå [8, 18]. Ïîâûøåíèå åãî àêòèâíîñòè ïðåæäå âñåãî îòðàæàåò âûñîêèé óðîâåíü èíòåíñèâíîñòè êàòàáîëè÷åñêèõ ïðîöåññîâ â ëèìôîöèòàõ ïðè ïåðèòîíèòå. Èíòåíñèâíîñòü àíàýðîáíîãî ãëèêîëèçà â ëèìôîöèòàõ áîëüíûõ ïåðèòîíèòîì ñíèæåíà, òàê êàê ó íèõ âûÿâëÿåòñÿ íèçêàÿ àêòèâíîñòü àíàýðîáíîé ðåàêöèè ËÄÃ. Ã6ÔÄà ÿâëÿåòñÿ êëþ÷åâûì è èíèöèàëèçèðóþùèì ôåðìåíòîì ïåíòîçîôîñôàòíîãî öèêëà, îò àêòèâíîñòè êîòîðîãî çàâèñèò øèðîêèé ñïåêòð ñèíòåòè÷åñêèõ ïðîöåññîâ [8, 10, 19]. Ñîîòâåòñòâåííî, ñíèæåíèå àêòèâíîñòè ôåðìåíòà â ëèìôîöèòàõ áîëüíûõ ïåðèòîíèòîì îïðåäåëÿåò çíà÷èòåëüíóþ íåäîñòàòî÷íîñòü ðåàêöèé ïëàñòè÷åñêîãî îáìåíà. Êðîìå òîãî, èçâåñòíî, ÷òî ÍÀÄÔÍ, îáðàçîâàííûé íà îêèñëèòåëüíîé ñòàäèè ïåíòîçîôîñôàòíîãî öèêëà, ìîæåò ïðèíèìàòü ó÷àñòèå â âîññòàíîâëåíèè îêèñëåííîãî ãëóòàòèîíà [20].  ñâÿçè ñ ýòèì ñíèæåíèå àêòèâíîñòè ÃÐ â êëåòêàõ áîëüíûõ ïåðèòîíèòîì ìîæåò îïðåäåëÿòüñÿ íåäîñòàòî÷íîñòüþ ÍÀÄÔÍ è îáóñëîâèòü àêòèâàöèþ ïåðåêèñíûõ ïðîöåññîâ.  òî æå âðåìÿ ýòèìè æå àâòîðàìè îòìå÷àåòñÿ âîçìîæíîñòü ñòèìóëÿöèè ñóáñòðàòíîãî ïîòîêà ïî ïåíòîçîôîñôàòíîìó öèêëó ïðè ïîâûøåíèè ñîäåðæàíèÿ â êëåòêàõ îêèñëåííîãî ãëóòàòèîíà [21]. Îäíàêî äèñáàëàíñ ìåòàáîëè÷åñêèõ ïðîöåññîâ â ëèìôîöèòàõ êðîâè ó áîëüíûõ ïåðèòîíèòîì ïðèâîäèò ê íàðóøåíèþ ðåãóëÿòîðíûõ âçàèìîñâÿçåé è, êàê ñëåäñòâèå, ñíèæåíèþ àêòèâíîñòè ÍÀÄÔ- è ÍÀÄÔÍ-çàâèñèìûõ ôåðìåíòîâ öèòîïëàçìàòè÷åñêîãî êîìïàðòìåíòà êëåòîê. ÍÀÄÔ-çàâèñèìàÿ èçîöèòðàòäåãèäðîãåíàçà îïðåäåëÿåòñÿ êàê âñïîìîãàòåëüíàÿ äåãèäðîãåíàçà öèêëà òðèêàðáîíîâûõ êèñëîò, îñóùåñòâëÿþùàÿ ñóáñòðàòíûé ïîòîê ïî öèêëó â óñëîâèÿõ ÍÀÄÍ-çàâèñèìîãî èíãèáèðîâàíèÿ ÍÀÄ-çàâèñèìûõ ôåðìåíòîâ öèêëà Êðåáñà [22, 23].  íàøåì èññëåäîâàíèè óñòàíîâëåíî, ÷òî àêòèâíîñòü ÌÄà (ÍÀÄ-çàâèñèìîé äåãèäðîãåíàçû ëèìîííîãî öèêëà) â ëèìôîöèòàõ áîëüíûõ ïåðèòîíèòîìñíèæåíà, òåì ñàìûì îïðåäåëÿÿ íèçêóþ èíòåíñèâíîñòü ñóáñòðàòíîãî ïîòîêà íà òåðìèíàëüíîì ýòàïå öèêëà Êðåáñà. Ïîäîáíîå ñîñòîÿíèå ìåòàáîëè÷åñêèõ ïðîöåññîâ â ìèòîõîíäðèàëüíîì êîìïàðòìåíòå ëèìôîöèòîâ ïàöèåíòîâ ñ ïåðèòîíèòîì ìîæåò îïðåäåëÿòüñÿ íèçêîé àêòèâíîñòüþ ïðÿìûõ è îáðàòíûõ ðåàêöèé ÍÀÄ- è ÍÀÄÔçàâèñèìîé ãëóòàìàòäåãèäðîãåíàç. Äàííûå ôåðìåíòû îñóùåñòâëÿþò âçàèìîäåéñòâèå öèêëà òðèêàðáîíîâûõ êèñëîò ñ ðåàêöèÿìè àìèíîêèñëîòíîãî îáìåíà, òàêæå ïðèíèìàÿ ó÷àñòèå â îáìåíå àçîòà [8]. Ñîñòîÿíèå àýðîáíîãî äûõàíèÿ íå òîëüêî çàâèñèò îò èíòåíñèâíîñòè ñóáñòðàòíîãî ïîòîêà ïî öèêëó Êðåáñà, íî è îïðåäåëÿåòñÿ óðîâíåì âîäîðîäíîãî ãðàäèåíòà â ìèòîõîíäðèÿõ. ÍÀÄÍ-ÌÄà ÿâëÿåòñÿ êëþ÷åâîé â ñèñòåìå ìàëàòàñïàðòàòíîãî øóíòà ìèòîõîíäðèé, ñîîòâåòñòâåííî, ñíèæåíèå åå àêòèâíîñòè îïðåäåëÿåò âîçìîæíîñòü ñíèæåíèÿ âîäîðîäíîãî ãðàäèåíòà ñ èíãèáèðîâàíèåì àýðîáíûõ ïðîöåññîâ â ëèìôîöèòàõ áîëüíûõ ÐÃÏ. Íåîáõîäèìî îòìåòèòü, ÷òî íèçêàÿ àêòèâíîñòü àýðîáíîé ðåàêöèè ËÄà òàêæå ìîæåò îòðèöàòåëüíî âëèÿòü íà óðîâåíü àýðîáíîãî äûõàíèÿ.  öåëîì óðîâåíü àêòèâíîñòè èññëåäóåìûõ ôåðìåíòîâ â ëèìôîöèòàõ êðîâè áîëüíûõ ïåðèòîíèòîì íåçíà÷èòåëüíî ðàçëè÷àåòñÿ â çàâèñèìîñòè îò èñõîäà çàáîëåâàíèÿ.  ñâÿçè ñ ýòèì, èñõîäÿ èç èíôîðìàòèâíîñòè ôåðìåíòîâ â ìîäåëè íåéðîñåòåâîãî êëàññèôèêàòîðà, ìû ïðåäëàãàåì ðàññ÷èòûâàòü ìåòàáîëè÷åñêèé êîýôôèöèåíò (ÌÊ), õàðàêòåðèçóþùèé ñîîòíîøåíèå Бюллетень сибирской медицины, 2014, том 13, № 5, с. 79–86 83 Савченко А.А.,.Здзитовецкий Д.Э., Лузан Н.А. Связь активности НАД-и НАДФ-зависимых дегидрогеназ лимфоцитов с исходом РГП àêòèâíîñòè ðåàêöèé ÍÀÄÔÍ-çàâèñèìîãî âîññòàíîâëåíèÿ ê óðîâíÿì ðåàêöèé ÍÀÄ-çàâèñèìîãî îêèñëåíèÿ: ÌÊ = (ÃÐ × ÍÀÄÔÍ-ÃÄÃ) / (ËÄÃ × ÌÄÃ) [24]. Ïðè âåëè÷èíå êîýôôèöèåíòà íèæå 0,005 ïðîãíîçèðóåòñÿ íåáëàãîïðèÿòíûé èñõîä çàáîëåâàíèÿ, ïðè âåëè÷èíå êîýôôèöèåíòà ðàâíîé è âûøå 0,005 – áëàãîïðèÿòíûé. Ïî ðåçóëüòàòàì ïðîâåäåííîãî îïðåäåëåíèÿ ÌÊ è ïåðñïåêòèâíîãî àíàëèçà èñõîäà çàáîëåâàíèÿ óñòàíîâëåíî, ÷òî ó 30 áîëüíûõ íàáëþäàëîñü ñîâïàäåíèå ïðîãíîçà (96,8% ñîâïàäåíèé). Èñõîä çàáîëåâàíèÿ â çíà÷èòåëüíîé ñòåïåíè îïðåäåëÿåòñÿ èíòåíñèâíîñòüþ ñèñòåìíîãî âîñïàëåíèÿ è óðîâíåì ïîëèîðãàííîé íåäîñòàòî÷íîñòè. Ñëåäñòâèåì ýòîãî ÿâëÿåòñÿ èçìåíåíèå ñîäåðæàíèÿ â ïåðèôåðè÷åñêîé êðîâè ðÿäà öèòîêèíîâ è äðóãèõ áèîëîãè÷åñêè àêòèâíûõ âåùåñòâ [7]. Ìîæíî ïðåäïîëîæèòü, ÷òî ðåãóëÿòîðíîå âëèÿíèå âñåãî êîìïëåêñà áèîëîãè÷åñêè àêòèâíûõ âåùåñòâ íà ëèìôîöèòû ìîäóëèðóåò èõ âíóòðèêëåòî÷íûé ìåòàáîëèçì è òåì ñàìûì ôîðìèðóåò õàðàêòåðíûé äëÿ èñõîäà ïåðèòîíèòà ñïåêòð óðîâíåé àêòèâíîñòè ÍÀÄ- è ÍÀÄÔ-çàâèñèìûõ äåãèäðîãåíàç. Заключение Òàêèì îáðàçîì, ó áîëüíûõ ñ íåáëàãîïðèÿòíûì èñõîäîì ÐÃÏ â ëèìôîöèòàõ êðîâè áîëåå âûðàæåííî ñíèæàåòñÿ àêòèâíîñòü ÍÀÄÔÌÄÃ, õàðàêòåðèçóþùàÿ èíòåíñèâíîñòü ðåàêöèé ëèïèäíîãî àíàáîëèçìà è êàòàáîëèçìà êñåíîáèîòèêîâ. Íåçàâèñèìî îò èñõîäà çàáîëåâàíèÿ â ëèìôîöèòàõ êðîâè áîëüíûõ ïåðèòîíèòîì ñíèæåíû óðîâíè àêòèâíîñòè ôåðìåíòîâ, îïðåäåëÿþùèõ èíòåíñèâíîñòü àíàýðîáíîãî è àýðîáíîãî äûõàíèÿ, à òàêæå óðîâåíü ïëàñòè÷åñêèõ ïðîöåññîâ ïðè àêòèâàöèè ðåàêöèé ëèïèäíîãî êàòàáîëèçìà è ïåðåíîñà ïðîäóêòîâ ÷åðåç Ã3ÔÄà íà îêèñëèòåëüíî-âîññòàíîâèòåëüíûå ðåàêöèè ãëèêîëèçà. Íåäîñòàòî÷íîñòü îáðàçîâàíèÿ ÍÀÄÔÍ â öèòîïëàçìàòè÷åñêîì êîìïàðòìåíòå ëèìôîöèòîâ ïðè ïåðèòîíèòå îïðåäåëÿåò íèçêóþ àêòèâíîñòü ðåàêöèè âîññòàíîâëåíèÿ ãëóòàòèîíà. Ñíèæåíèå ñóáñòðàòíîãî ïîòîêà íà óðîâíå òåðìèíàëüíûõ ðåàêöèé öèêëà òðèêàðáîíîâûõ êèñëîò îáóñëîâëåíî íàðóøåíèåì âçàèìîäåéñòâèÿ ñ ðåàêöèÿìè àìèíîêèñëîòíîãî îáìåíà. Èñõîäÿ èç èíôîðìàòèâíîñòè óðîâíåé àêòèâíîñòè ÍÀÄ- è ÍÀÄÔ-çàâèñèìûõ äåãèäðîãåíàç â íåéðîñåòåâîé ìîäåëè ïðè êëàññèôèêàöèè ïî èñõîäó çàáîëåâàíèÿ, ïðåäëàãàåòñÿ ìåòàáîëè÷åñêèé êîýôôèöèåíò, îáëàäàþùèé ïðîãíîñòè÷åñêîé çíà÷èìîñòüþ. Литература 1. Ñóêîâàòûõ Á.Ñ., Áëèíêîâ Þ.Þ., Áóêðååâà À.Å., Åøòîêèí Ñ.À., Èâàíîâ Ï.À., Æóêîâñêèé Â.À. Ïðèìåíåíèå èììîáèëèçîâàííûõ ôîðì ãèïîõëîðèòà íàòðèÿ â êîìïëåêñíîì ëå÷åíèè ðàñïðîñòðàíåííîãî ãíîéíîãî ïåðèòî84 íèòà // Âåñòíèê õèðóðãèè èì. È.È. Ãðåêîâà. 2011.Ò. 170, ¹ 6. Ñ. 32–36. 2. Wiest R., Krag A., Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond // Gut. 2012. V. 61, ¹ 2. P. 297–310. 3. Ñàâ÷åíêî À.À., Áîðèñîâ À.Ã. Îñíîâû êëèíè÷åñêîé èììóíîìåòàáîëîìèêè. Íîâîñèáèðñê: Íàóêà, 2012. 263 ñ. 4. Adam T., Waickman A.T., Powell J.D. mTOR, metabolism, and the regulation of T-cell differentiation and function // Immunol. Rev. 2012. V. 249, ¹ 1. P. 43–58. 5. Zeng H., Chi H. mTOR and lymphocyte metabolism // Curr. Opin. Immunol. 2013. V. 25, ¹ 3. P. 347–355. 6. Êàïóñòèíà Ò.À., Ñàâ÷åíêî À.À., Ïàðèëîâà Î.Â., Êîëåí÷óêîâà Î.À., Ìàðêèíà À.Í., Áåëîâà Å.Â. Îñîáåííîñòè èììóíèòåòà ó áîëüíûõ ñ ïàòîëîãèåé âåðõíåãî ðåñïèðàòîðíîãî òðàêòà õëàìèäèéíîé ýòèîëîãèè // Æóðíàë ìèêðîáèîëîãèè, ýïèäåìèîëîãèè è èììóíîáèîëîãèè. 2008. ¹ 3. Ñ. 94–95. 7. Sista F., Schietroma M., Santis G.D., Mattei A., Cecilia E.M., Piccione F., Leardi S., Carlei F., Amicucci G. Systemic inflammation and immune response after laparotomy vs laparoscopy in patients with acute cholecystitis, complicated by peritonitis // World J. Gastrointest. Surg. 2013. V. 5, ¹ 4. P. 73–82. 8. Áèîõèìèÿ / ïîä ðåä. Å.Ñ. Ñåâåðèíà. Ì.: ÃÝÎÒÀÐ-Ìåäèà. 2004. 784 ñ. 9. Jiang P., Du W., Mancuso A., Wellen K.E., Yang X. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence // Nature. 2013. V. 493, ¹ 7434. P. 689–693. 10. Jiang P., Du W., Yang X. A critical role of glucose-6phosphate dehydrogenase in TAp73-mediated cell proliferation // Cell Cycle. 2013. V. 12, ¹ 24. P. 3720–3726. 11. Le Gall J.-R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study // JAMA. 1993. V. 270. P. 2957–2963. 12. Ñàâåëüåâ Â.Ñ., Ôèëèìîíîâ Ì.È., Ãåëüôàíä Á.Ð. Ïðîãðàììèðóåìûé ïåðèòîíåàëüíûéëàâàæ â ëå÷åíèè ðàñïðîñòðàíåííîãî ïåðèòîíèòà // Àííàëû õèðóðãèè. 1996. ¹ 3. Ñ. 25–29. 13. Linder M.M., Wacha H., Feldmann U., Wesch G., Streifensand R.A., Gundlach E. Der Mannheimer Peritonitis-Index. Ein Instrument zur intraoperativen Prognose der Peritonitis // Chirurg. 1987. V. 58. P.84–91. 14. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., Reinhart C.K., Suter P.M., Thijs L.G. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine // Intensive Care Med. 1996. V. 22, ¹ 7. P. 707–710. 15. Bone R.S., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M., Sibbald W.J. American college of Chest Physicians. Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guide lines for the use of innovative therapies in sepsis // Crit. CareMed. 1992. V. 20, ¹ 6. P. 864–874. 16. Ñàâ÷åíêî À.À., Ñóíöîâà Ë.Í. Âûñîêî÷óâñòâèòåëüíîå îïðåäåëåíèå àêòèâíîñòè äåãèäðîãåíàç â ëèìôîöèòàõ ïåðèôåðè÷åñêîé êðîâè áèîëþìèíåñöåíòíûì ìåòîäîì // Ëàá. äåëî. 1989. ¹ 11. Ñ. 23–25. 17. Ãîðáàíü À.Í. Îáó÷åíèå íåéðîííûõ ñåòåé. ÑÏá: ÏàðàÃðàô, 1990. 160 ñ. 18. de la Roche M., Tessier S.N., Storey K.B. Structural and functional properties of glycerol-3-phosphate dehydrogenase from a mammalian hibernator // Protein J. 2012. V. 31, ¹ 2. P. 109–119. Бюллетень сибирской медицины, 2014, том 13, № 5, с. 79–86 Оригинальные статьи 19. Ham M., Lee J.W., Choi A.H., Jang H., Choi G., Park J., Kozuka C., Sears D.D., Masuzaki H., Kim J.B. Macrophage glucose-6-phosphate dehydrogenase stimulates proinflammatory responses with oxidative stress // Mol. Cell. Biol. 2013. V. 33, ¹ 12. P. 2425–2435. 20. Ãàâðèëþê Ë.À., Êîð÷ìàðó È.Ô., Ðîáó Ì.Â. Àêòèâíîñòü ãëóòàòèîíçàâèñèìûõ ýíçèìîâ è ãëþêîçî-6-ôîñôàòäåãèäðîãåíàçû â êðîâè áîëüíûõ ëèìôîãðàíóëåìàòîçîì // Ãåìàòîëîãèÿ è òðàíñôóçèîëîãèÿ. 2009. Ò. 54, ¹ 2. Ñ. 11–13. 21. Ãàâðèëþê Ë.À., Êîð÷ìàðó È.Ô., Ðîáó Ì.Â., Ëûñûé Ë.Ò. Ãëóòàòèîí-çàâèñèìûå ôåðìåíòû è ãëþêîçî-6-ôîñôàòäåãèäðîãåíàçà â êðîâè áîëüíûõ ëèìôîñàðêîìîé (Íåõîäæêèíñêîé ëèìôîìîé) // Áèîìåäèöèíñêàÿ õèìèÿ. 2011. Ò. 57. Âûï. 2. Ñ. 225– 31. 22. Kim S., Kim S.Y., Ku H.J., Jeon Y.H., Lee H.W., Lee J., Kwon T.K., Park K.M., Park J.W. Suppression of tumorigenesis in mitochondrial NADP(+)-dependent isocitrate dehydrogenase knock-out mice // Biochim. Biophys. Acta. 2014. V. 1842, ¹ 2. P. 135–143. 23. Lee J.H., Park J.W. Attenuated mitochondrial NADP+dependent isocitrate dehydrogenase activity induces apoptosis and hypertrophy of H9c2 cardiomyocytes // Biochimie. 2014. V. 99. P. 110–118. 24. Ïàò. 2498300 ÐÔ, ÌÏÊ G01N 33/48 (2006.01), G01N 33/68 (2006.01). Ñïîñîá ïðîãíîçèðîâàíèÿ èñõîäà ðàñïðîñòðàíåííîãî ãíîéíîãî ïåðèòîíèòà / À.À. Ñàâ÷åíêî, Ä.Ý. Çäçèòîâåöêèé, Þ.Ñ. Âèííèê, À.Ã. Áîðèñîâ, Í.À. Ëóçàí. Îïóáë. 10.11.2013, Áþë. ¹ 31. 8 ñ. Ïîñòóïèëà â ðåäàêöèþ 23.04.2014 ã. Óòâåðæäåíà ê ïå÷àòè 09.10.2014 ã. 뇂˜ÂÌÍÓ Ä̉ÂÈ Ä̇ÚÓθ‚˘ () – ä-ð ìåä. íàóê, ïðîôåññîð, ëàáîðàòîðèÿ ìîëåêóëÿðíî-êëåòî÷íîé ôèçèîëîãèè è ïàòîëîãèè ÍÈÈ ìåäèöèíñêèõ ïðîáëåì Ñåâåðà ÑÎ ÐÀÌÍ (ã. Êðàñíîÿðñê). á‰ÁËÚӂˆÍËÈ ÑÏËÚËÈ ù‰Û‡‰Ó‚˘ – êàíä. ìåä. íàóê, äîöåíò êàôåäðû è êëèíèêè õèðóðãè÷åñêèõ áîëåçíåé èì. ïðîô. Þ.Ì. Ëóáåíñêîãî ÊÃÌÓ èì. ïðîô. Â.Ô. Âîéíî-ßñåíåöêîãî (ã. Êðàñíîÿðñê). ãÛÁ‡Ì ç‡Ú‡Î¸fl Ä̇ÚÓθ‚̇, ëàáîðàòîðèÿ ìîëåêóëÿðíî-êëåòî÷íîé ôèçèîëîãèè è ïàòîëîãèè ÍÈÈ ìåäèöèíñêèõ ïðîáëåì Ñåâåðà ÑÎ ÐÀÌÍ (ã. Êðàñíîÿðñê). 뇂˜ÂÌÍÓ Ä̉ÂÈ Ä̇ÚÓθ‚˘, òåë.: +7-9059713715; e-mail: [email protected] COMMUNICATION OF NAD- AND NADP-DEPENDENT DEHYDROGENASE ACTIVITIES IN LYMPHOCYTES WITH OUTCOME OF PREVALENCE PURULENT PERITONITIS Savchenko A.A.1, Zdzitovetsky D.E.2, Luzan N.A.1 1 2 Institute of Medical Problems of the North, Krasnoyarsk, Russian Federation Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetsky, Krasnoyarsk, Russian Federation ABSTRACT Aim of this study was to investigate of NAD(P)-dependent dehydrogenases activity in lymphocytes at different outcomes widespread purulent peritonitis(WPP). Enzyme activity in blood lymphocytes was determined by bioluminescent method. Found that patients with a poor outcome of WPP in blood lymphocytes made more pronounced reaction of lipid anabolism and catabolism of xenobiotics. Regardless of the outcome of the disease in blood lymphocytes of WPP patients reduced levels of enzymes activity that determine the intensity of anaerobic and aerobic respiration and the level of plastic processes, but the activation reactions of lipid catabolism and transport products through glycerol-3-phosphate dehydrogenase on reactions of glycolysis. Based on the informativeness of the NAD(P)-dependent dehydrogenases activity in the classification neural network model for the disease outcome, metabolic coefficient is proposed, which has prognostic significance. KEY WORDS: widespread purulent peritonitis, disease outcome, NAD-dependent dehydrogenases, NADP-dependent dehydrogenases, lymphocytes, metabolism. Bulletin of Siberian Medicine, 2014, vol. 13, no. 5, pp. 79–86 References 1. Sukovatyh B.S., BlinkovJu.Ju., Bukreeva A.E., Eshtokin S.A., Ivanov P.A., Zhukovskij V.A. Application of immobilized forms of sodium hypochlorite in the complex treatment of a widespread purulent peritonitis. Vestnik khirurgii im. I.I. Grekova – Herald of Surgery them. I.I. Grekova, 2011, vol. 170 no. 6, pp. 32–36 (in Russian). Бюллетень сибирской медицины, 2014, том 13, № 5, с. 79–86 85 Савченко А.А.,.Здзитовецкий Д.Э., Лузан Н.А. Связь активности НАД-и НАДФ-зависимых дегидрогеназ лимфоцитов с исходом РГП 2. Wiest R., Krag A., Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut, 2012, vol. 61, no. 2, pp. 297–310. 3. Savchenko A.A., Borisov A.G. Osnovy klinicheskoy immunometabolomiki [Basics of clinical immunometabolomics]. Novosibirsk, Nauka Publ., 2012. 263 pp (in Russian). 4. Adam T., Waickman A.T., Powell J.D. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol. Rev., 2012, vol. 249, no. 1, pp. 43–58. 5. Zeng H., Chi H. mTOR and lymphocyte metabolism. Curr. Opin. Immunol., 2013, vol. 25, no. 3, pp. 347–355. 6. Kapustina T.A., Savchenko A.A., Parilova O.V., Kolenchukova O.A., Markina A.N., Belova E.V.Features immunity in patients with pathology of the upper respiratory tract of chlamydial etiology. Zhurnal mikrobiologii, epidemiologii i immunobiologii – Journal of Epidemiology and Microbiology, Immunobiology, 2008, no. 3, pp. 94–95 (in Russian). 7. Sista F., Schietroma M., Santis G.D., Mattei A., Cecilia E.M., Piccione F., Leardi S., Carlei F., Amicucci G. Systemic inflammation and immune response after laparotomy vs laparoscopy in patients with acute cholecystitis, complicated by peritonitis. World J. Gastrointest. Surg., 2013, vol. 5, no. 4, pp. 73–82. 8. Biokhimiya [Biochemistry]. Ed. E.S. Severin. Moscow, GAOTAR-Media Publ., 2004. 784 pp (in Russian). 9. Jiang P., Du W., Mancuso A., Wellen K.E., Yang X. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature, 2013, vol. 493, no. 7434, pp. 689–693. 10. Jiang P., Du W., Yang X. A critical role of glucose-6phosphate dehydrogenase in TAp73-mediated cell proliferation. Cell Cycle, 2013, vol. 12, no. 24, pp. 3720–3726. 11. Le Gall J.-R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA, 1993, vol. 270, pp. 2957–2963. 12. Savel'ev V.S., Filimonov M.I., Gel'fand B.R. Programmable peritoneal lavage in the treatment of widespread peritonitis. Annaly khirurgii – Annals of Surgery, 1996, no. 3, pp. 25– 29 (in Russian). 13. Linder M.M., Wacha H., Feldmann U., Wesch G., Streifensand R.A., Gundlach E. Der Mannheimer Peritonitis-Index. Ein Instrument zurintraoperativenPrognose der Peritonitis. Chirurg, 1987, vol. 58, pp. 84–91. 14. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., Reinhart C.K., Suter P.M., Thijs L.G. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med., 1996, vol. 22, no. 7, pp. 707–710. 15. Bone R.S., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M., Sibbald W.J. American college of Chest Physicians. Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guide lines for the use of innovative therapies in sepsis. Crit. Care Med., 1992, vol. 20, no. 6, pp. 864–874. 16. Savchenko A.A., Suncova L.N. Highly sensitive detection of dehydrogenase activity in peripheral blood lymphocytes by the bioluminescent method. Lab. delo, 1989, no. 11, pp. 23– 25 (in Russian). 17. Gorban' A.N. Obuchenie neyronnykh setey [Training Neural Networks]. St. Petersburg: ParaGraf Publ., 1990, 160 pp (in Russian). 18. de la Roche M., Tessier S.N., Storey K.B. Structural and functional properties of glycerol-3-phosphate dehydrogenase from a mammalian hibernator. Protein J., 2012, vol. 31, no. 2, pp. 109–119. 19. Ham M., Lee J.W., Choi A.H., Jang H., Choi G., Park J., Kozuka C., Sears D.D., Masuzaki H., Kim J.B. Macrophage glucose-6-phosphate dehydrogenase stimulates proinflammatory responses with oxidative stress. Mol. Cell. Biol., 2013, vol. 33, no. 12, pp. 2425–2435. 20. Gavriljuk L.A., Korchmaru I.F., Robu M.V.Activity of glutathione-dependent enzymes and glucose-6-phosphate dehydrogenase in the blood of patients with Hodgkin's disease. Gematologija i transfuziologija – Hematology and Blood Transfusion, 2009, vol. 54, no. 2, pp. 11–13 (in Russian). 21. Gavriljuk L.A., Korchmaru I.F., Robu M.V., Lysyj L.T. Glutathione-dependent enzymes and glucose-6-phosphate dehydrogenase in the blood of patients with lymphosarcoma (NonHodgkin’s lymphoma). Biomeditsinskaya khimiya – Biochemistry, 2011, vol. 57, no. 2, pp. 225–231 (in Russian). 22. Kim S., Kim S.Y., Ku H.J., Jeon Y.H., Lee H.W., Lee J., Kwon T.K., Park K.M., Park J.W. Suppression of tumorigenesis in mitochondrial NADP(+)-dependent isocitrate dehydrogenase knock-out mice. Biochim. Biophys. Acta, 2014, vol. 1842, no. 2, pp. 135–143. 23. Lee J.H., Park J.W. Attenuated mitochondrial NADP+dependent isocitrate dehydrogenase activity induces apoptosis and hypertrophy of H9c2 cardiomyocytes. Biochimie, 2014, vol. 99, pp. 110–118. 24. Savchenko A.A., Zdzitovetsky D.Ye., Vinnik Yu.S., Borisov A.G., Luzan N.A. Sposob prognozirovaniya iskhoda rasprostranennogo gnoynogo peritonita [The method of predicting the outcome of widespread purulent peritonitis]. Patent no. 2498300 Russia, MPK G01N 33/48 (2006.01), G01N 33/68 (2006.01), Published 10.11.2013, Bull. no. 31, 8 p. (in Russian). Savchenko Andrei A. (), Institute of Medical Problems of the North, Siberian Division, Russian Academy of Medical Sciences, Krasnoyarsk, Russian Federation. Zdzitovetsky Dmitry E., Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetsky, Krasnoyarsk, Russian Federation. Luzan Natal'ya A., Institute of Medical Problems of the North, Siberian Division, Russian Academy of Medical Sciences, Krasnoyarsk, Russian Federation. Savchenko Andrei A., Ph. +7-9059713715; e-mail: [email protected] 86 Бюллетень сибирской медицины, 2014, том 13, № 5, с. 79–86